FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/04/051970 [Registered on: 25/04/2023] Trial Registered Prospectively
Last Modified On: 24/04/2023
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Single Arm Study 
Public Title of Study   Use of a new tool to assess myocardial dysfunction in heart failure with preserved ejection fraction 
Scientific Title of Study   ESTIMATION OF MYOCARDIAL WORK BY ECHOCARDIOGRAPHY IN PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Abhinav Aggarwal 
Designation  DM SR 
Affiliation  VMMC and SJH 
Address  Heart command centre, Ground Floor, department of Cardiology, super speciality block, Safdurjung Hospital

South
DELHI
110029
India 
Phone  9999833130  
Fax    
Email  drabhinav1007@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Anwar Hussain Ansari 
Designation  Professor 
Affiliation  VMMC and SJH 
Address  Heart command centre, Ground Floor, department of Cardiology, super speciality block, Safdurjung Hospital

South
DELHI
110029
India 
Phone  9999833130  
Fax    
Email  anwarhussain72@yahoo.co.in  
 
Details of Contact Person
Public Query
 
Name  Abhinav Aggarwal 
Designation  DM SR 
Affiliation  VMMC and SJH 
Address  Heart command centre, Ground Floor, department of Cardiology, super speciality block, Safdurjung Hospital

South
DELHI
110029
India 
Phone  9999833130  
Fax    
Email  drabhinav1007@gmail.com  
 
Source of Monetary or Material Support  
None 
 
Primary Sponsor  
Name  Safdarjung hospital  
Address  Heart command centre, Ground Floor, department of Cardiology, super speciality block, Safdurjung Hospital 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Abhinav Aggarwal  Safdurjung Hospital  Room number 737,Department of Cardiology, super speciality block, Safdarjung Hospital, Ansari Nagar East,, New Delhi, Delhi 110029
South
DELHI 
9999833130

drabhinav1007@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Review Board/Thesis protocol review committee Safdurjung Hospital  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: I503||Diastolic (congestive) heart failure,  
 
Intervention / Comparator Agent  
Type  Name  Details 
 
Inclusion Criteria  
Age From  35.00 Year(s)
Age To  99.00 Year(s)
Gender  Both 
Details  1) Patients with unexplained dyspnea or fatigue with LV ejection fraction of more than or equal
to 50% on transthoracic echocardiography with no apparent cause of HF symptoms other than
HFpEF
2) Age ≥ 35 years 
 
ExclusionCriteria 
Details  1) Significant valvular disease: severe AS,AR,MS,MR
2) Pericardial diseases
3) Prosthetic heart valve or prosthetic ring
4) Obstructive heart lesions(myxomas)
5) Congenital heart disease
6) Severe anaemia
7) Severe COPD
8) Poor acoustic window 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
myocardial work by echocardiography in patients with heart failure with preserved
ejection fraction. 
at baseline 
 
Secondary Outcome  
Outcome  TimePoints 
correlation of myocardial work and global longitudinal strain(GLS) with NT Pro
BNP levels and pulmonary capillary wedge pressure(PCWP). 
at baseline 
 
Target Sample Size   Total Sample Size="70"
Sample Size from India="70" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   07/05/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   Not published yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Heart failure (HF) is defined as the inability of the heart to pump blood to the body at a rate
commensurate with its needs, or to do so only at the cost of high filling pressures. The new
guidelines classify patients with HF in three categories: heart failure with preserved ejection
fraction (HFpEF), defined by an LVEF ≥50%, heart failure with reduced ejection fraction (HFrEF)
if the LVEF is <40%, and heart failure with mid-range ejection fraction (HFmrEF) if the LVEF is 40–
49%. Patients with heart failure are at a higher risk for subsequent repeat exacerbations of
symptoms requiring hospitalization as well as cardiovascular death.

The reference gold standard to diagnose HFpEF in patients is right-sided heart catheterization
followed by invasive exercise testing if resting intracardiac pressures are normal. Patients with
HFpEF are identified by elevated pulmonary capillary wedge pressure at rest (≥15 mm Hg) or
during exercise (≥25 mm Hg)
.

Research suggests that LV systolic reserve disturbances may lead to the reduction of exercise
capacity in patients with HFpEF. Traditional measurement of Left ventricular performance with
ejection fraction (EF) is notably subjective, with many limitations and interobserver variability,
while tissue Doppler Imaging has technical issues including preload and afterload dependence,
and limitations in its ability to assess all planes of LV deformation. Recently, echocardiography
parameters like speckle tracking imaging with global longitudinal strain (GLS) is being used to
assess subtle myocardial dysfunction as this is a more objective measure but this too remains
limited by its load dependency, as increase in the afterload may decrease the GLS and lead to
false interpretations about LV contractility.

To overcome these issues, a new echocardiographic tool called myocardial work (MW) has been
developed to non-invasively measure the LV pressure–strain relationship. MW is calculated as
LV pressure applied over strain and is a non-invasive method for LV performance evaluation. It
incorporates both LV afterload and deformation. MW analysis is less load-dependent if
compared with global longitudinal strain, and therefore could provide incremental information
in the setting of HF patients. Thus, myocardial work is affected earlier as compared to global
longitudinal strain. It is estimated by employing non-invasive brachial artery blood pressure and
LV GLS. The estimated LV pressure curve is calculated using an empiric reference pressure curve.
Along with MW, its components are also calculated, namely: global work index (GWI), global
work efficiency (GWE), global constructive work (GCW) and global wasted work (GWW).

Despite MW being an index of LV performance, there have only been a few studies of MW In
HFpEF patients. These studies have shown that these patients have impaired GLS, enhanced WW
and reduced myocardial work efficiency (MWE). MW analysis has been suggested to help
differentiate patients with impending LV systolic decompensation. Research has also shown that
low GWI is a predictor of severely impaired LV function, inadequate cardiopulmonary exercise,
and increased NT-proBNP levels, all of which are markers of poor prognosis. They concluded that
in HFpEF patients, GWW showed high accuracy to predict the first HFpEF hospitalization and its
association with mortality. In addition, preclinical subtle myocardial damage in HFpEF could
potentially be detected by MW.

Despite the enormity of this subject, there have been a very small number of studies worldwide
and none at all in India about the role of myocardial work in patients with HFpEF. Despite
extensive search of literature, we could not find any study on the correlation between
myocardial work parameters and the gold standard of HFpEF diagnosis, i.e pulmonary capillary
wedge pressure. This avenue has the potential to alter algorithms for the prevention,
investigation, diagnosis, treatment and follow up of patients with HFpEF, highlighting the need
for future large research in this field.

AIM
To evaluate myocardial work indices and global longitudinal strain by echocardiography in
patients with Heart failure with preserved ejection fraction.

Primary objective:
To evaluate myocardial work by echocardiography in patients with heart failure with preserved
ejection fraction.

Secondary objective:
To study the correlation of myocardial work and global longitudinal strain(GLS) with NT Pro
BNP levels and pulmonary capillary wedge pressure(PCWP).
 
Close